Literature DB >> 33372010

Unilateral persistent disc oedema due to cerebral sinus venous thrombosis (CSVT): diagnostic and management challenge.

Rohan Nalawade1, Mohan Kannam1, Butchi Raju Garuda2, Virender Sachdeva3.   

Abstract

A 50-year-old woman was incidentally diagnosed to have unilateral disc oedema during comprehensive ophthalmological evaluation. She had a prior history of ulcerative colitis. She had normal visual function and was initially diagnosed to have incipient non-arteritic anterior ischaemic optic neuropahty. Risk factor evaluation revealed hyperhomocysteinaemia. She was asked to come for a follow-up in 2 months. However, she was lost to follow-up and returned to the clinic for the evaluation for headaches, 23 months later. Her ocular examination was stable and she had persistent unilateral disc oedema unchanged from the prior visit. Repeat MRI brain and MR venogram brain with contrast-established diagnosis of cerebral sinus venous thrombosis (CSVT). She denied any neurological symptoms. Later on, she was diagnosed to have hyperhomocysteinaemia with methyl tetrahydrofolate reductase gene mutation. This case highlights the importance of recognising although rare, unilateral disc oedema secondary to elevated intracranial pressure from CSVT. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  neuroimaging; neuroopthalmology

Mesh:

Substances:

Year:  2020        PMID: 33372010      PMCID: PMC7772298          DOI: 10.1136/bcr-2020-234997

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  1 in total

1.  Clinical profile, diagnostic challenges, and outcomes in subacute/chronic cerebral sinus venous thrombosis.

Authors:  Virender Sachdeva; Rohan Nalawade; Mohan Kannam; Rajat Kapoor; Goura Chattannavar; Sheetal Bajirao Kale; Jenil Sheth; Akshay Badakere; Debasmita Majhi; Vivekanand Uttamrao Warkad; Pratik Chougule; Ramesh Kekunnaya
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.